Today: 7 February 2026
Subscribe
Browse Category

NYSE:FUBO News 7 December 2025 - 22 December 2025

fuboTV Inc. (FUBO) Stock News Today: Disney-Hulu Integration, NBCUniversal Blackout Fallout, and Analyst Price Targets on December 22, 2025

fuboTV Inc. (FUBO) Stock News Today: Disney-Hulu Integration, NBCUniversal Blackout Fallout, and Analyst Price Targets on December 22, 2025

fuboTV Inc. (NYSE: FUBO) heads into the final stretch of 2025 as a very different company than it was a year ago—and the stock is trading like it. As of December 22, 2025, FUBO shares were around $2.71 (latest trade time shown: 11:42 UTC), reflecting a small rebound after a rocky late-November to mid-December stretch that’s been dominated by a high-stakes distribution fight with NBCUniversal and the messy reality of operating a “new” pay-TV giant under Disney’s controlling ownership. What’s making FUBO particularly interesting (and, yes, particularly chaotic) is that investors are trying to price three storylines at once: Below
22 December 2025
·
FuboTV (FUBO) Stock in December 2025: Price Cuts, Hulu + Live TV Merger and NBCU Dispute — Latest News, Forecasts and Analysis

FuboTV (FUBO) Stock in December 2025: Price Cuts, Hulu + Live TV Merger and NBCU Dispute — Latest News, Forecasts and Analysis

Updated: December 7, 2025 – informational only, not financial advice. Where FuboTV Stock Stands Right Now After a volatile year, FuboTV Inc. (NYSE: FUBO) heads into mid‑December 2025 at around $2.85 per share, the closing price on Friday, December 5.Investing.com+1 That price leaves FUBO: The company’s market cap is just under $1 billion and it trades at a trailing price‑to‑sales ratio of roughly 0.6x and a trailing P/E around 8–9x, unusually low for a streaming name but complicated by non‑recurring items and the Hulu + Live TV transaction.Ticker Nerd+1 Technically, things look rough in the very short term: So while
7 December 2025
··

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Go toTop